Various combinations of the genes cryIVA (cry4A), cryIVD (cry11A), and p20 from Bacillus thuringiensis subsp. israelensis were introduced into the nitrogen-fixing cyanobacterium Anabaena sp. strain PCC 7120 by means of Escherichia coli-Anabaena shuttle vector pRL488p and were expressed under control of two tandem strong promoters, a cyanobacterial promoter (PpsbA) and an E. coli T7 promoter (P A1 ). Two of the clones carrying cryIVA plus cryIVD, one with p20 and one without p20, displayed toxicity against third-instar larvae of Aedes aegypti at levels greater than any level previously reported for transgenic cyanobacteria.
Bacillus thuringiensis subsp. israelensis has been used widely to control mosquitoes and blackflies, which are vectors of human infectious diseases (19) . The larvicidal activity of this organism is contained in a parasporal crystalline inclusion (␦-endotoxin) synthesized during sporulation (7) . A 75-MDa plasmid includes all of the genes responsible for ␦-endotoxin production (4) . B. thuringiensis subsp. israelensis is widely accepted as a biological pesticide because of its highly specific activity against dipteran insects without adverse effects on other organisms and because no resistance has been developed by the target mosquito larvae (14) .
Current applications of B. thuringiensis subsp. israelensis for mosquito control are limited by the short half-life of existing preparations under field conditions (33) . One way to overcome this limitation is by cloning the genes coding for the B. thuringiensis subsp. israelensis toxin in organisms inhabiting the breeding zones of mosquitoes and used by them as a food source (5, 27) . Cyanobacteria have been considered attractive candidates for this purpose (5, 6, 33) . Several attempts have been made during the last decade to produce transgenetic mosquitocidal cyanobacteria (2, 9, 17, 22, 23, 25, 31) . Some success has been achieved in expressing single cry genes in unicellular strains, but the intact transformed cells displayed levels of mosquito larvicidal activity below the level required for effective and practical use as bioinsecticides in a natural aquatic environment (2, 9, 17, 22) . Attempts to enhance expression of cryIV genes in cyanobacteria by strong inherent promoters (e.g., P psbA [9] and P cpcB [17] ) were not satisfactory, probably because the transcription or translation products were unstable (22, 23 ). An engineered organism carrying a combination of toxin genes might be expected to be a substantial improvement due to possible synergistic interactions, such as those that occur in Escherichia coli (3) . In addition, when more than one gene is responsible for larvicidal activity, the concern that resistance might develop in mosquitoes is diminished (14) .
In the present study, combinations of the genes cryIVA (cry4A), cryIVD (cry11A), and p20, previously cloned and expressed in E. coli (3) as operons (in pUHE), were introduced into the nitrogen-fixing filamentous cyanobacterium Anabaena sp. strain PCC 7120. The most toxic clones were selected for further study.
P20 improved the expression level of cytA (cyt1Aa), cryIVA (cry4A), and cryIVD (cry11A) in E. coli (1, 3, 28, 32) and in an acrystalliferous strain of B. thuringiensis (8, 30) , probably by acting as a chaperonin for stabilizing the gene products. Synergism among purified CryIVA, CryIVB, and CryIVD was clearly demonstrated (10, 18) , with the highest degree of synergism occurring between CryIVA and CryIVD.
Construction of shuttle vector for expression. Recombinants pHE4-ADR and pHE4-AD (containing cryIVA plus cryIVD, with and without p20, respectively [3] ) were found by KpnI-PstI double digestion to contain a single KpnI site located downstream of cryIVA (data not shown). This site was deleted to produce plasmids pHE4-ADR(ϪK) (Fig. 1 ) and pHE4-AD (ϪK), which were necessary for further construction (see below), by digesting pHE4-ADR and pHE4-AD with KpnI and filling the sticky ends with T4 polymerase to form blunt ends, which were ligated by T4 DNA ligase. The other vector, pBS-SK/N, had been constructed previously to include a promoter and operator (P/O), a ribosome binding site (RBS), and an NcoI site by inserting a 135-bp PstI-XhoI fragment from pUHE24-2 (3) into the polylinker of pBlueScriptII SK ϩ (24) . P/O is a repressible promoter derived from the early T7 promoter P A1 combined with two tandem lacO operators (3). DNA modification enzymes and restriction enzymes were used as recommended by the suppliers (New England BioLabs and United States Biochemical, respectively). Plasmids were introduced into E. coli HB101, DH5␣, or XL-Blue MRFЈ by transformation. Competent cells were prepared, and plasmids were isolated by standard procedures (20) .
The cryIVADR and cryIVAD operons (containing cryIVA and cryIVD, with and without p20, respectively) were transferred from pHE4-ADR(ϪK) and pHE4-AD(ϪK) into pBS-SK/N by NcoI-PstI double digestion to produce pSBJ1 and pSBW1, respectively, which were then united with pRL488p at their unique KpnI sites (see above). The latter plasmid had been prepared by inserting a 1-kb SalI-KpnI fragment containing the strong constitutive promoter P psbA from pRL435K (kindly sup-plied by Y. Hirshberg) into the shuttle vector pRL488 (13) . The final constructs (about 23 and 22 kb long) with the cryIVADR and cryIVAD operons under control of the tandem promoters were designated pSBJ2 and pSBW2, respectively.
The clone with cryIVA alone was constructed from pHE4-ADR like pSBJ1 and pSBW1 were constructed, but without removal of the KpnI site (downstream of cryIVA) (see above), as follows. The cryIVADR operon was transferred from pHE4-ADR into pBS-SK/N by NcoI-PstI double digestion to produce pSBJ1(ϩK). A 3.6-kb KpnI fragment containing cryIVA (with P/O and a RBS) was isolated and inserted into the unique KpnI site of pRL488p to create pSBJ3 (16.6 kb).
Similarly, pSB4-D, pSB4-DR, and pSB4-A were constructed by joining pUCE4-D, pUCE4-DR, and pUCE4-A (3), respectively, with pRL488p at their unique KpnI sites. These plasmids contained a single promoter, P psbA , and were used as control constructs for comparison.
Introduction of cryIV genes into Anabaena sp. strain PCC 7120. The recombinant shuttle expression vectors containing cryIV genes were introduced into Anabaena sp. strain PCC 7120 by triparental conjugation mating with E. coli (12) . E. coli HB101 harboring each of the constructed plasmids and helper plasmid pRL528 (12) was mixed with E. coli J53 containing conjugal plasmid RP4 and with Anabaena sp. strain PCC 7120 pregrown in BG11 liquid medium at 28°C without stirring under cool white fluorescent light illumination. The mixed suspensions were spread onto nitrocellulose membranes over BG11 agar plates. After 24 h of incubation, the membranes were transferred to selective plates containing neomycin (25 g ml Ϫ1 ), and colonies that formed on the membranes about 10 days later were inoculated into 5 ml of BG11 medium supplemented with neomycin. After 1 week, when true exconjugant clones had grown, each clone was inoculated into a flask and cultivated under the same conditions. Among the approximately 100 clones tested (see below), two independent pSBJ2 clones carrying cryIVADR (designated clones 7 and 11) were found to be toxic to larvae of Aedes aegypti. Similarly, four pSBW2 clones containing cryIVAD (designated clones 1, 2, 5, and 6) and one pSBJ3 clone containing cryIVA (designated clone 16) were selected for further study. The clones were then freed of contaminating E. coli by repeated streaking on agar plates and were shown to grow well in BG11 liquid medium containing neomycin, as measured by the concentration of chlorophyll in methanol extracts (16) .
Mosquito larvicidal activities. For bioassays, cells (of E. coli DH5␣ and Anabaena sp. strain PCC 7120) without lacI were cultivated in the appropriate liquid medium, harvested by centrifugation, and resuspended in distilled water. Samples were then added together with 10 or 20 third-instar larvae of Aedes aegypti to disposable cups containing 50 or 100 ml of sterile tap water, respectively, and the larvicidal activities were determined after incubation for 24 h at 28°C (3, 15) . The concentrations of cells which killed 50% of the exposed population in a standard bioassay (LC 50 ) were determined by probit analysis by performing duplicate bioassays at each of six doses.
Six clones of Anabaena sp. strain PCC 7120, two carrying cryIVADR (pSBJ2) and four carrying cryIVAD (pSBW2), exhibited very high toxicity against Aedes aegypti larvae, as did their E. coli counterparts harboring the same plasmids ( Table  1 ). The LC 50 of clones containing cryIVADR and cryIVAD were equal to or less than 9 ϫ 10 4 cells ml Ϫ1 (0.8 g of total soluble protein ml Ϫ1 ) at 24 h and 3 ϫ 10 4 cells ml Ϫ1 (0.27 g of total soluble protein ml Ϫ1 ) at 48 h, which is the lowest reported value for engineered cyanobacterial cells with B. thuringiensis subsp. israelensis toxin genes (2, 9, 17, 22, 23).
Even though P psbA was reported to be a strong cyanobacterial promoter (11, 26) , construct pSB4-A with this promoter alone was much less toxic than pSBJ3 with two tandem promoters (P psbA and P A1 ) (Table 1) . Similarly, neither pSB4-D nor pSB4-DR showed any toxicity. The phenomenon of improved expression of cry genes with tandem promoters has been described previously (22) .
Plasmid recovery and stability. Plasmid pSBJ2 was isolated from several colonies of E. coli XL-Blue MRFЈ cells transformed with total DNA prepared from clone 11. Selection of transformed cells was done on Luria-Bertani agar plates containing ampicillin and kanamycin (each at a concentration of FIG. 1. The cryIVADR operon was transferred from pHE4-ADR(ϪK) to pBS-SK/N by NcoI-PstI double digestion to form pBSJ1, which was then joined with expression shuttle vector pRL488p at its unique KpnI site. The resulting hybrid recombinant plasmid was designated pSBJ2. . 50 g ml Ϫ1 ). The plasmids extracted from the cells were found to be structurally intact. Cultures of E. coli transformed with the isolated plasmids were as toxic as the original clone (data not shown).
The Anabaena sp. strain PCC 7120 cultures carrying the various combinations of cryIV genes were repeatedly subcultured for 1 year under selective pressure. The toxicities of the subcultures were assayed at every passage (about six generations), and no major differences were found (data not shown). Cells of clone 11 carrying the largest plasmid with high toxicity grew as vigorously as the wild-type cells (data not shown), indicating that pSBJ2 at least is quite stable inside Anabaena sp. strain PCC 7120 and that the constitutive expression of cryIV toxins is not harmful to the host cells.
The plating efficiency (fraction of CFU on selective plate out of the total viable cells) of clone 11 after growth on nonselective medium was more than 95% (data not shown). The toxicity was slightly lower, possibly due to a decrease in the number of plasmid copies during growth in nonselective medium for at least 1 month (6 generations) (data not shown).
All of the recombinant plasmids in the clones of Anabaena sp. strain PCC 7120 contained the pDU1-based replicon, which was originally isolated from the filamentous cyanobacterium Nostoc sp. (12) . This replicon seems to be stable in Anabaena sp. strain PCC 7120, but upon expression of genes 51 and 42 of Bacillus sphaericus 2297 its toxicity was found to decrease slightly when the organism was grown without selection (31). It is not clear whether this decrease in toxicity is attributable to a loss of plasmids or to modification of the plasmids or toxin products.
Comparison to previous studies. This is the first report of constitutive expression of high mosquito larvicidal activity by transgenic Anabaena sp. strain PCC 7120 with combinations of two ␦-endotoxin genes (cryIVA and cryIVD) and regulatory gene p20 of B. thuringiensis subsp. israelensis. The cyanobacterium Agmenellum quadruplicatum PR-6, transformed with cryIVD behind its own strong phycocyanin promoter (P cpcB ), produced inclusion bodies and was mosquitocidal, but the onset of toxicity with Culex pipiens larvae (fed at 12-h intervals from hatching) was delayed (high mortality occurred only after 5 days [17] ). The mortality of second-instar Aedes aegypti larvae after 48 h of exposure to transgenic Agmenellum quadruplicatum PR-6 expressing cryIVB (10 mg of total protein ml Ϫ1 ) under the same promoter (P cpcB ) was 45% (2). When cryIVB was expressed in the unicellular cyanobacterium Synechocystis sp. strain PCC 6803 from the same promoter that was used here (P psbA ), the levels of the toxic polypeptide were very low and whole cells were not mosquitocidal at a concentration of 4 ϫ 10 8 cells ml Ϫ1 (9) . Using tandem promoters for expression of cryIVB (its own promoter and lacP) in Synechococcus sp. strain PCC 7942 increased the mosquitocidal activity, but the activity remained relatively low. Mortality of first-instar larvae of Culex restuans fed once daily became apparent after only 2 days (22) .
The toxicities of our clones (expressing cryIVA and cryIVD, with and without p20, under P psbA and P A1 in Anabaena sp. strain PCC 7120) were substantially higher; the LC 50 after 24 h was about 9 ϫ 10 4 cells ml Ϫ1 or 0. (18) . In this study, no significant difference was found between the toxicities and stabilities of clones with and without p20, even though a role for P20, probably as a chaperonin, has been proposed for high levels of expression in other systems (1, 3, 28, 32) . Several reasons other than synergism and strong tandem promoters could explain the high toxicity levels obtained in this study. The appropriate RBS and the corresponding codon usage should increase translation efficiency in the transgenic organism. The codon usage of the four cry genes of B. thuringiensis subsp. israelensis (23) resembles that of Anabaena sp. (29) but not that of Synechocystis sp. strain PCC 7942 (23, 29) . In this study a high level of toxicity was observed with recombinant clones of Anabaena sp. strain PCC 7120 suitable for mosquito control. However, laboratory strains with foreign genes cannot succeed in nature, because their adaptive values are low compared with those of indigenous species. So far, a dry powder prepared by lyophilization of recombinant cells has retained the same high toxicity as the original culture (data not shown). Use of such a preparation should facilitate wide application of the transgeneric strains. However, the present formulation may not be economic. We plan to reintroduce an indigenous strain, such as Anabaena siamensis, containing the constructs into its natural habitat for effective control of mosquitoes (5, 6, 33) . In the meantime, a recombinant strain lacking competitiveness and therefore bound to have a short life in the field is safe to use, since the probability of recombinant DNA leaking into other organisms by horizontal gene flow is much lower than the probability that this will occur with longlasting recombinants. Field application of the latter organisms would certainly require much more stringent measures for control and gene containment, such as a recently reported method (21) in which workers used a recombinase-mediated system for elimination of the antibiotic resistance gene marker from genetically engineered B. thuringiensis strains.
